News & AnalysisAllergy Care platform Nectar inks $8m seedNectar, an allergy care platform, has secured $8 million in seed funding.ByIris Dorbian17 March 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs